Childhood pancreatic neuroendocrine neoplasms: A national experience
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31258 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Tiphaine Courtel und 15 weiteren Autor:innen. Beteiligte Einrichtung: Unité d'Onco-Hémato-Immunologie pédiatrique, CHU Angers, Angers, France. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Pancreatic neuroendocrine neoplasms (pNENs) diagnosed in childhood are very rare, with few data available. The aim was to describe the clinical presentation and behavior of children with pNENs at a national level.
Methods
National multicenter retrospective study of all patients, aged from 0 to 17 years at diagnosis, treated from 2011 to 2020 for a pNEN and registered in the French National Registry of Childhood Cancers or FRACTURE database.
Results
Fifteen patients, 13 well‐differentiated pancreatic neuroendocrine tumors (pNETs) and two neuroendocrine carcinomas (pNECs), were selected. Median age at diagnosis was 14 years (range, 7–17). Eight patients, all with localized disease, had a cancer predisposition syndrome (CPS), including five cases diagnosed during systematic screening. Five (31%) had metastatic disease at diagnosis: three grade 2 pNETs and two pNECs. First line therapy included exclusive pancreatectomy (seven cases, all M0), active surveillance (three cases, all M0), medical therapies (somatostatin analogues, chemotherapy; four cases, all M1), and surgery with medical therapy (one M1 case). Three‐year progression‐free survival was 57% (confidence interval [CI] 95%: 27–78) and was significantly better for patients with low‐grade well differentiated (73 vs. 0%; p < 10 −4 ) and localized (76 vs. 20%; p = .02) tumors. The two patients with pNECs died. Three‐year overall survival was 92% (CI95%: 59–99) and was significantly better in patients with low‐grade tumor (100 vs. 50%; p = 10 −4 ).
Conclusion
Childhood pNENs occur more frequently in adolescents with CPS. Localized low‐grade pNETs in children have a very good prognosis, whereas the treatment of high‐grade and metastatic pNETs/pNECs should be better defined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unité d'Onco-Hémato-Immunologie pédiatrique, CHU Angers, Angers, France.
- SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, Paris-Saclay University (PSL), Paris, France.
- French National Registry of Childhood Solid Tumors, CHU Nancy, Nancy, France.
- Inserm UMR 1153, Centre of Research in Epidemiology and StatisticS (CRESS), Paris University, Epidemiology of Childhood and Adolescent Cancers Team (EPICEA), Paris, France.
- Plateforme de recherche clinique pédiatrique, CHU Angers, Angers, France.
- Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.
ORCID-Profile: Daniel Orbach, Hervé Brisse, Brice Fresneau, Coralie Mallebranche
Zitieren
APA
Courtel, T., Orbach, D., Lacour, B., Roumy, M., Hescot, S., Desandes, E., Philippe-Chomette, P., Sarnacki, S., Irtan, S., Dijoud, F., Kubicek, P., Brisse, H., Fresneau, B., Pire, A., Réguerre, Y., & Mallebranche, C. (2025). Childhood pancreatic neuroendocrine neoplasms: A national experience. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31258
Vancouver
Courtel T, Orbach D, Lacour B, Roumy M, Hescot S, Desandes E, et al. Childhood pancreatic neuroendocrine neoplasms: A national experience. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31258
BibTeX
@article{Courtel2025,
author = {Courtel, Tiphaine and Orbach, Daniel and Lacour, Brigitte and Roumy, Marianne and Hescot, Ségolène and Desandes, Emmanuel and Philippe-Chomette, Pascale and Sarnacki, Sabine and Irtan, Sabine and Dijoud, Frédérique and Kubicek, Pierre and Brisse, Hervé and Fresneau, Brice and Pire, Aurore and Réguerre, Yves and Mallebranche, Coralie},
title = {Childhood pancreatic neuroendocrine neoplasms: A national experience},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31258}
}
EUVIMED